CytoBioScience, Inc. announced that it has entered into a security purchase agreement for best efforts private placement of 2,040,000 units at a price of $0.75 per unit for gross proceeds of $1,530,000 on February 26, 2018. The transaction will include participation from BOCO Investment, LLC, and Shing Leong Hui. Each unit consists of one common share and one share purchase warrant. The warrants will mature in three years from the closing. The company will issue securities pursuant to exemption provided under Regulation D.